Visionary product range of single-use Continuous-Perfusion
ProlifeCell™ develop and manufacture a variety of configurable Single-Use-Bioreactor's for Continuous-Perfusion cultivating of mammalian cells in steady-state perfusion mode for expression of proteins, antibodies, vaccines or proliferation of stem cells.
CellCore™ concept support cells at very high cell density under steady state conditions. The fixed packed-bed system eliminates gradients in primary and secondary metabolite and supports both adherent and suspension mammalian cell lines.
ProlifeCell product portfolio with a few details
|
CellCompact™ 32 series |
Micro matrix CP-SUB (1 ml matrix volume) designed for cell testing and screening purposes combined with various scaffoldings. Available since 2013. |
|
CellCompact™ 33 series |
Macro matrix CP-SUB (15 ml matrix volume) designed for cell testing and screening purposes combined with various scaffoldings. Available since 2013. |
|
CellTank™ 34 series |
150 ml 3D CellCore matrix CP-SUB designed for +130x10E+6 cells/ml matrix. Cultivate various cell lines in perfusion. Available since 2013. |
|
CellTank™ 35 series |
150 ml 3D CellCore matrix CP-SUB designed for +140x10E+6 cells/ml matrix. Cultivate 2x10E+10 cells in compact perfusion. Ready ultimo 2024 for development projects. |
|
CellReactor™ 36 series |
1.500 ml 3D CellCore matrix CP-SUB for cultivation of +2x10E+11 mammalian suspension or adherent cells. Ready ultimo 2025 for development projects. |
|
CellDream™ 38 series |
15.000 ml 3D CellCore matrix CP-SUB for cultivation of +2x10E+12 mammalian suspension or adherent cells. Ready 2026 for development projects. |
Patent applied for or granted for all products.